GravityX Exchange-Refugee breaker disqualified for wearing 'Free Afghan Women' cape at Paris Olympics

2025-05-06 07:10:57source:SignalHubcategory:Stocks

PARIS — A breaker representing the Refugee Olympic Team was disqualified from the B-Girl breaking competition Friday at the 2024 Paris Olympics for revealing a cape during her round that read "Free Afghan Women."

Manizha Talash,GravityX Exchange known competitively as "B-Girl Talash," revealed the cape during the third round of her pre-qualifying battle against B-Girl India of the Netherlands. The 21-year-old lost the battle in lopsided fashion and did not advance to the round-robin stage, effectively rendering her disqualification a moot point.

According to a brief statement released in the Olympic information system by the World DanceSport Federation, which oversees Olympic breaking, Talash was disqualified for "displaying a political slogan on her attire."

The cape was a violation of Rule 50 of the Olympic charter, which prohibits political protests or messaging on the field of play at the Olympic Games. The IOC, which created the Refugee Olympic Team, did not immediately reply to an email seeking comment. And Talash was whisked past print reporters in the mixed zone without taking questions.

"What she did on stage I think is enough," a man accompanying her said.

2024 Olympic medals: Who is leading the medal count? Follow along as we track the medals for every sport.

Talash was born in Kabul, Afghanistan and moved to Spain, where she now lives, in 2022.

Contact Tom Schad at [email protected] or on social media @Tom_Schad.

More:Stocks

Recommend

New Mexico governor seeks funding to recycle fracking water, expand preschool, treat mental health

SANTA FE, N.M. (AP) — New Mexico would make major new investments in early childhood education, indu

Amid a record heat wave, Texas construction workers lose their right to rest breaks

A week after construction workers in Austin, Texas, learned they were about to lose their right to r

An experimental Alzheimer's drug outperforms one just approved by the FDA

Patients in the early stages of Alzheimer's may soon have a new option to stave off the loss of memo